Biodesix Inc (BDSX)
1.51
+0.11
(+7.86%)
USD |
NASDAQ |
May 06, 10:54
Biodesix Debt to Equity Ratio: 7.702 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.702 |
| September 30, 2023 | -17.29 |
| June 30, 2023 | -3.533 |
| March 31, 2023 | 5.524 |
| December 31, 2022 | 1.216 |
| September 30, 2022 | -6.619 |
| June 30, 2022 | 2.655 |
| March 31, 2022 | 1.299 |
| December 31, 2021 | 0.5075 |
| Date | Value |
|---|---|
| September 30, 2021 | 1.871 |
| June 30, 2021 | 1.283 |
| March 31, 2021 | 0.9068 |
| December 31, 2020 | 0.6745 |
| September 30, 2020 | -0.2122 |
| June 30, 2020 | -1.308 |
| March 31, 2020 | |
| December 31, 2019 | -0.1598 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-17.29
Minimum
Sep 2023
7.702
Maximum
Dec 2023
-0.3427
Average
0.7907
Median
Debt to Equity Ratio Benchmarks
| Fonar Corp | 0.0008 |
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 0.2077 |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 99.10M |
| Total Liabilities (Quarterly) | 94.52M |
| Shareholders Equity (Quarterly) | 4.58M |
| Current Ratio | 1.188 |
| Net Debt Paydown Yield | -1.81% |